Literature DB >> 26786489

Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis.

Chaitali Nikam1, Mubin Kazi1, Chandrasekhar Nair2, Majula Jaggannath2, Manoj M2, Vinaya R2, Anjali Shetty1, Camilla Rodrigues3.   

Abstract

To evaluate the performance of TrueNAT (RT Micro PCR device) assay in comparison with GeneXpert on sputum samples from pulmonary cases of tuberculosis. 274 samples were processed to detect MTB by ZN smear examination, MGIT culture and molecular methods that included RT-PCR (ABI 7500 & TrueNAT) and GeneXpert for case detection of TB. The overall performance of the test with MGIT(Mycobacterium Growth Indicator Tube) culture as gold standard, sensitivity of smear, RT PCR/TrueNAT and Genexpert was 61.5% (CI:53.3-69.3%), 94.7% (CI:89.8-97.6%) & 96.0% (CI: 91.5-98.5%), respectively. Amongst the S+ (108) samples, RT-PCR/TrueNAT and GeneXpert showed a sensitivity of 99% (CI:94.9%-99.8%) and 100% (98.6%-100.0%), respectively. High concordance was observed between GeneXpert and TrueNAT for case detection of TB. The GeneXpert MTB/RIF test was independent on the user's skills. It has a short turn-around time and simultaneously detects RIF resistance with M. tuberculosis in less than 3h. The TrueNAT MTB has good sensitivity and specificity in case detection with hands on time of less than 3h as well as fits the requirements in resourcelimited health care settings. Larger, multi-site studies are required to obtain better estimates of the performance of TrueNAT MTB.
Copyright © 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GeneXpert; Pulmonary tuberculosis; RT PCR; TrueNAT MTB

Year:  2014        PMID: 26786489     DOI: 10.1016/j.ijmyco.2014.04.003

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  16 in total

Review 1.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Authors:  Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

2.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

3.  Integrated nucleic acid testing system to enable TB diagnosis in peripheral settings.

Authors:  Hsiang-Wei Lu; Rama Sakamuri; Pranav Kumar; Tanya M Ferguson; Robert W Doebler; Keith D Herrington; Ryan P Talbot; Kris M Weigel; Felicia K Nguyen; Gerard A Cangelosi; Masahiro Narita; David S Boyle; Angelika Niemz
Journal:  Lab Chip       Date:  2020-10-27       Impact factor: 6.799

4.  Impact and operational feasibility of TrueNat MTB/Rif under India's RNTCP.

Authors:  K Jeyashree; D Shanmugasundaram; K Rade; R R Gangakhedkar; M V Murhekar
Journal:  Public Health Action       Date:  2020-09-21

Review 5.  Review of Current COVID-19 Diagnostics and Opportunities for Further Development.

Authors:  Yan Mardian; Herman Kosasih; Muhammad Karyana; Aaron Neal; Chuen-Yen Lau
Journal:  Front Med (Lausanne)       Date:  2021-05-07

6.  Diagnosis and Treatment of Childhood Pulmonary Tuberculosis: A Cross-Sectional Study of Practices among Paediatricians in Private Sector, Mumbai.

Authors:  Carolyn Kavita Tauro; Nilesh Chandrakant Gawde
Journal:  Interdiscip Perspect Infect Dis       Date:  2015-08-26

7.  Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.

Authors:  David J Lee; Nagalingeswaran Kumarasamy; Stephen C Resch; Gomathi N Sivaramakrishnan; Kenneth H Mayer; Srikanth Tripathy; A David Paltiel; Kenneth A Freedberg; Krishna P Reddy
Journal:  PLoS One       Date:  2019-07-02       Impact factor: 3.240

Review 8.  Guidelines for Preoperative Testing for Neurosurgery in Coronavirus Disease 2019 (COVID-19) Era: Indian Viewpoint Amidst Global Practice.

Authors:  Nitish Agarwal; Amol Raheja; Ashish Suri
Journal:  World Neurosurg       Date:  2020-10-24       Impact factor: 2.104

9.  Quality matters: Redefining child TB care with an emphasis on quality.

Authors:  Farhana Amanullah; Jason Michael Bacha; Lucia Gonzalez Fernandez; Anna Maria Mandalakas
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-11-02

10.  Validity of a CB-NAAT assay in diagnosing tuberculosis in comparison to culture: A study from an urban area of South India.

Authors:  Aishwarya Raj; Shrikala Baliga; M Suchitra Shenoy; B Dhanashree; P Prasanna Mithra; Smitha K Nambiar; Leesha Sharon
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.